2016 - Present
Establishment of Designed Cells Central Research Institute,
a growth engine for ground-breaking study
- Patent registration of “Stem cells for dementia therapy” (USA, Europe, China, Australia, Japan)
- Patent registration of “Stem cells for beauty”
- Patent registration of “Glaucoma treatment methods”
- Patent registration of “Stem cells for stroke therapy”
- Establishment of Designed Cells Co., Ltd.
- Establishment of Designed Cells Central Research Institute
- Funding from Daewon Investment Co. and Biotoxtech Inc.
- Establishment of Qingdao Sinder Designed Stem Cells (QSDSC) China
- Contract for the establishment of Designed Cells Viet Nam (DCVN)
- Certification of Quality Management System ISO 9001:2015
- Patent registration of “Exosome-rich conditioned medium (ERCM) for cosmetics”
- Patent registration of “Exosome-rich conditioned medium (ERCM) for arthritis therapy”
- Patent registration of “White rose extracts for skin whitening & wrinkle care” (China)
- Paper publication of “Stem cell therapy of arthritis”
- Patent registration of “Nattokinase for thrombolysis”
- Paper publication of “Stem cells encoding functional genes for stroke therapy”
- Paper publication of “Stem cells encoding functional genes for Alzheimer’s disease therapy”
- Funding from ITX-AI Co.
- M&A with COSON Co.
- MOA for the establishment of Designed Cells Health Care (DCHC) Iraq
- Patent submission of “Canine stem cells and exosome-rich conditioned medium (ERCM) for anti-inflammation”
- Patent submission of “Feline stem cells and exosome-rich conditioned medium (ERCM) for anti-inflammation”
2011 - 2015
Research & development of stem cells and bioactive materials to treat incurable diseases
- Paper publication of “Stem cells encoding functional genes for dementia therapy”
- Patent registration of “Stem cells for the dementia therapy”
- Patent submission of “Stem cells for dementia therapy” (USA, Europe, China, Australia, Japan)
- Paper publication of “Anti-aging activity of stem cells”
- Patent submission of “Stem cells for cerebral palsy therapy”
- Patent submission of “Stem cells for beauty”
- Patent submission of “Glaucoma treatment methods”
- Patent submission of “Stem cells for stroke therapy”
- Paper publication of “Health span-extending activity of stem cells”
1978 - 2011
The World’s first isolation of neural stem cells (NSCs) and establishment of stem cells encoding functional genes
- Establishment of culture method for human NSCs [Professor Seung U. Kim (UBC Hospital in Canada)] – Adviser of Designed Cells Co., Ltd.]
- Pure culture of oligodendrocytes, and application as a study model of multiple sclerosis
- Establishment of immortalized human NSC lines
- Establishment of NSCs encoding functional genes for Alzheimer disease therapy
- Patent submission of “Stem cells for dementia therapy”
- Clinical trial of “Stem cells encoding functional gene for malignant brain tumor therapy” (City of Hope Cancer Treatment and Research Center, CA, USA)